- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Niemann-Pick B
Total 6619 results
-
International Extranodal Lymphoma Study Group (IELSG)TerminatedDiffuse Large B-Cell Lymphoma of the Breast
-
Korea Cancer Center HospitalUnknownRelapsed or Refractory Marginal Zone B-cell LymphomaKorea, Republic of
-
Jennifer Crombie, MDMerck Sharp & Dohme LLCRecruitingPrimary Mediastinal Large B-cell Lymphoma (PMBCL) | Primary Mediastinal Large B Cell Lymphoma | T-Cell/Histiocyte-Rich Large B-Cell Lymphoma | Primary Mediastinal Large B-Cell Lymphoma Refractory | Primary Mediastinal Large B-Cell Lymphoma Recurrent | Epstein-Barr Virus Positive Diffuse Large...United States
-
National Cancer Institute (NCI)Active, not recruitingDiffuse Large B-Cell Lymphoma | High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements | Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | Double-Expressor Lymphoma | EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | High Grade B-Cell Lymphoma, Not Otherwise... and other conditionsUnited States
-
C. R. BardTerminatedNo Specific Conditions Under Study. Primary Focus: Adult Subjects Who Require PICC PlacementUnited States
-
University Hospital, BrestUnknown
-
Incyte Biosciences Italy S.r.lAdvice Pharma Group srlRecruiting
-
University of Alabama at BirminghamNot yet recruitingLymphoma, Follicular | Lymphoma, B-Cell | Diffuse Large B Cell LymphomaUnited States
-
The First Affiliated Hospital of Xiamen UniversityShanxi Province Cancer Hospital; Sun Yat-sen University; Jiangsu Provincial People... and other collaboratorsRecruiting
-
Regeneron PharmaceuticalsRecruitingDiffuse Large B-cell Lymphoma (DLBCL)United States, Spain, Korea, Republic of, Italy, Belgium, Austria, Thailand, Singapore, Turkey, France, Israel, Australia, Czechia, Poland, Chile, United Kingdom, Germany
-
Ruijin HospitalNot yet recruitingLymphoma | DLBCL - Diffuse Large B Cell LymphomaChina
-
University Health Network, TorontoRecruitingDLBCL - Diffuse Large B Cell LymphomaCanada
-
Chengdu Zenitar Biomedical Technology Co., LtdRecruitingStudy of Purinostat Mesylate for Injection in the Treatment of Diffuse Large B-cell Lymphoma (DLBCL)Diffuse Large B Cell Lymphoma,DLBCLChina
-
Sun Yat-sen UniversityRecruitingDouble Express Diffuse Large B-cell LymphomaChina
-
Li ZhimingAntengene CorporationRecruitingDLBCL Germinal Center B-Cell TypeChina
-
Nordic Lymphoma GroupRoche Pharma AGRecruitingDiffuse Large B Cell Lymphoma | DLBCLFinland, Norway, Denmark, Italy, Sweden, Australia, New Zealand
-
University of Wisconsin, MadisonMedical College of WisconsinRecruitingCancer | Diffuse Large B Cell Lymphoma | DLBCLUnited States
-
Xynomic Pharmaceuticals, Inc.RecruitingDiffuse Large B-cell Lymphoma (DLBCL)China
-
Fudan UniversityXiangya Hospital of Central South University; Shanghai Changzheng Hospital; Baotou...Active, not recruitingDiffuse Large B-cell Lymphoma(DLBCL)China
-
Antengene CorporationTerminatedRelapsed/Refractory Diffuse Large B-cell LymphomaChina
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH); Fogarty...CompletedHIV | Diffuse Large B-cell LymphomaMalawi
-
Cellular Biomedicine Group Ltd.The First Affiliated Hospital with Nanjing Medical UniversityCompletedRefractory Diffuse Large B-Cell LymphomaChina
-
Lymphoma Study AssociationAmgenCompletedUntreated CD20-positive Large B-cell LymphomaFrance
-
The Lymphoma Academic Research OrganisationHoffmann-La RocheTerminatedDiffuse Large B Cell Lymphoma CD20 PositiveFrance, Belgium
-
Neumedicines Inc.UnknownLymphoma, Large B-Cell, Diffuse (DLBCL)
-
BeBetter Med IncRecruitingRelapsed/Refractory Diffuse Large B-Cell LymphomaChina
-
University Medical Center GroningenStichting Hemato-Oncologie voor Volwassenen NederlandRecruitingNHL | DLBCL - Diffuse Large B Cell LymphomaNetherlands
-
National Health Research Institutes, TaiwanNational Taiwan University Hospital; Mackay Memorial Hospital; China Medical... and other collaboratorsRecruitingGastric Diffuse Large B-cell LymphomaTaiwan
-
Novartis PharmaceuticalsCompletedDiffuse Large B-cell Lymphoma (DLBCL)United States, Japan, Australia, Italy, Canada, Germany, Norway, Netherlands, France, Austria
-
BeiGeneCompletedRelapsed/Refractory Diffuse Large B-Cell LymphomaChina
-
H. Lee Moffitt Cancer Center and Research InstituteKite, A Gilead CompanyActive, not recruitingDiffuse Large B Cell Lymphoma | Transformed LymphomaUnited States
-
Barbara Ann Karmanos Cancer InstituteWithdrawnRelapsed Diffuse Large B-cell LymphomaUnited States
-
Novartis PharmaceuticalsCompletedDiffuse Large B-cell Lymphoma (DLBCL)United States
-
Jiangsu Cancer Institute & HospitalUnknownDiffuse Large B-Cell Lymphoma (DLBCL)China
-
Cancer Institute and Hospital, Chinese Academy...UnknownDiffuse Large B-cell Lymphoma | Rituximab | ToripalimabChina
-
Hospital Universitario Principe de AsturiasUnknownDiffuse Large B-Cell Lymphoma (DLBCL)Spain
-
City of Hope Medical CenterNational Cancer Institute (NCI)TerminatedRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell LymphomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | CD20 PositiveUnited States
-
AstraZenecaWithdrawnCore: Relapsed or Refractory Diffuse Large B-Cell Lymphoma | Module 1: Non-GCB Diffuse Large B-Cell Lymphoma
-
Chongqing Precision Biotech Co., LtdRecruiting
-
Masonic Cancer Center, University of MinnesotaRecruitingDiffuse Large B Cell Lymphoma | DLBCL | High-grade B-cell Lymphoma | DLBCL Arising From Follicular LymphomaUnited States
-
National Taiwan University HospitalNot yet recruitingAntibiotics-unresponsive MALT Lymphoma | Relapsed MALT Type Extranodal Marginal Zone B-Cell Lymphoma | Refractory Extranodal Marginal Zone B-Cell Lymphoma (MALT)Taiwan
-
Czech Lymphoma Study GroupHoffmann-La Roche; Ministry of Health, Czech RepublicCompletedDiffuse Large B-Cell Lymphoma. | Primary Mediastinal B-Cell Lymphoma | Follicular Lymphoma Grade IIICzech Republic
-
National Cancer Institute (NCI)RecruitingRecurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell LymphomaUnited States
-
Novartis PharmaceuticalsRecruitingAcute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia | Diffuse Large B-cell Lymphoma | Small Lymphocytic Lymphoma | Large B-cell LymphomaJapan, Australia, Germany, Italy, Spain, France, Austria, United States
-
Shanghai YingLi Pharmaceutical Co. Ltd.UnknownB-cell Chronic Lymphocytic Leukemia | B-cell Lymphoma RecurrentChina
-
SynthekineRecruitingFollicular Lymphoma | Mantle Cell Lymphoma | Diffuse Large B Cell Lymphoma | NHL | CLL/SLL | Large B-cell Lymphoma | Indolent B-Cell Non-Hodgkin LymphomaUnited States
-
Medical College of WisconsinMiltenyi Biomedicine GmbHActive, not recruitingB-cell Chronic Lymphocytic Leukemia | B-cell Non Hodgkin LymphomaUnited States
-
Hebei Senlang Biotechnology Inc., Ltd.Tongji HospitalRecruiting19 and 22+ B Cell Hematologic Tumors | 19 and 20+ B Cell Hematologic TumorsChina
-
The Lymphoma Academic Research OrganisationActive, not recruitingRefractory Indolent Adult Non-Hodgkin Lymphoma | Refractory Mantle Cell Lymphoma | Diffuse Large B-Cell Lymphoma Refractory | Refractory Transformed B-cell Non-Hodgkin Lymphoma | Refractory Primary Mediastinal Large B-Cell Cell LymphomaFrance